Digital illustration symbolizing pandemic preparedness.

Are We Ready? Gauging the Nation's Pandemic Preparedness

"A 2015 report reveals strengths and weaknesses in US laboratory and epidemiology capacity to handle a major influenza outbreak."


The threat of influenza pandemics is a persistent concern for global health. The 2009 H1N1 pandemic and the ongoing emergence of avian influenza viruses, like H7N9, underscore the need for constant vigilance and preparedness. Understanding a nation's readiness is crucial for effective response strategies.

In 2015, the Centers for Disease Control and Prevention (CDC) conducted a comprehensive assessment called the Pandemic Influenza Readiness Assessment (PIRA) to evaluate the preparedness of the United States for the next influenza pandemic. This assessment focused on the laboratory and epidemiology capacities of public health jurisdictions across the country.

This article delves into the key findings of the PIRA report, providing insights into the strengths and weaknesses of the U.S. public health system in detecting, responding to, and managing a potential influenza pandemic. By understanding these findings, we can better prepare for future threats and ensure the health and safety of our communities.

AI Search Multiple angles on this topic

Measuring Preparedness

The national inventory of core capabilities for pandemic influenza preparedness and response uses indicators as reasonable proxies or measures of preparedness and response capability. This framing supports planning and evaluation, but the source does not provide a single definitive statistic for national readiness.

Key Findings from the Pandemic Influenza Readiness Assessment

Digital illustration symbolizing pandemic preparedness.

The PIRA report, which included responses from all 62 Public Health Emergency Preparedness (PHEP) awardee jurisdictions, revealed a mixed bag of capabilities. While many jurisdictions demonstrated strong capacities in certain areas, gaps remained that could hinder an effective pandemic response.

A significant portion of jurisdictions reported the ability to perform essential laboratory and epidemiology tasks. These included:

  • Differentiating novel influenza A viruses from seasonal influenza viruses.
  • Electronically transferring laboratory, surveillance, and case investigation data.
  • Transferring electronic death records.
  • Conducting surveillance for influenza-associated mortality in adults.
AI Search Multiple angles on this topic

Surveillance and Early Detection

The 2015 U.S. and territories Pandemic Influenza Readiness Report describes laboratory and epidemiologic data as vital for identifying a novel influenza A virus and informing public health response. The Oregon Child Absenteeism Due to Respiratory Disease Study (ORCHARDS), conducted in Oregon, WI, monitors influenza-like-illness-specific student absenteeism daily in kindergarten through Grade 12 and assesses its potential for early detection of accelerated transmission. A CDC mapping of the U.S. domestic influenza virologic surveillance landscape reports that surveillance relies on specimens collected from symptomatic patients during medical encounters, where testing is primarily for diagnosis rather than surveillance. A 2026 study on resilient, response-ready influenza vaccination programs focuses on middle-income countries and notes a lack of information about the factors that contribute to program resilience.

Capacity Gaps and Planning Challenges

During the H1N1 response in the San Francisco Bay Area, laboratory capacity often helped local health departments investigate disease and implement control measures, but testing capacity varied across the region and even well-equipped laboratories exceeded their capacity. A 2012–2013 survey of diagnostic testing in U.S. hospitals cautioned that reliance on insensitive assays to detect influenza may detract from optimal clinical management. The CDC says pandemics occur infrequently, yet planning is important because response is complex and pandemics can affect everyone in a community. Its National Pandemic Strategy aims to limit spread, mitigate disease, suffering and death, and sustain infrastructure while mitigating economic impact.

Diagnostics and Epidemiology Capacity

A report on developing diagnostics for the novel coronavirus 2019-nCoV described two one-step real-time reverse transcription polymerase chain reaction assays reported by Chu and colleagues. Separately, the 2017 assessment of state health department epidemiology capacity found substantial to full capacity for investigating health problems in 92% of departments and monitoring health status in 84%. Capacity was lower for evaluating effectiveness, at 39%, and applied research, at 29%. These findings describe different parts of preparedness: diagnostic assay development and the uneven distribution of epidemiology capabilities.

Despite these strengths, the assessment also identified areas where improvements were needed. A key concern was the ability of all jurisdictions to rapidly identify and characterize novel influenza strains. Ensuring that all states and territories have and maintain critical capacities requires additional planning and technical assistance.

Moving Forward: Strengthening Our Defenses

The PIRA report serves as a valuable tool for guiding future efforts to enhance pandemic preparedness in the United States. By addressing the identified gaps and building upon existing strengths, the nation can be better equipped to face the inevitable challenges posed by future influenza pandemics. Continuous investment in public health infrastructure, training, and research is essential to protect the health and well-being of our communities.

AI Search Multiple angles on this topic

Building Readiness for the Next Pandemic

The CDC explains that a pandemic can occur when a new influenza A virus can easily infect and spread among people. A 2021 review of influenza pandemic preparedness surveys its history and current state and proposes additional measures for improvement. The U.S. National Academy of Medicine initiative, launched in 2020, was designed to collect, understand, and leverage lessons from COVID-19 for the next influenza pandemic; it produced four outputs, according to a 2023 article. WHO identifies regularly updating national influenza pandemic plans and building surveillance and response capacity through seasonal epidemics and zoonotic outbreaks as essential preparedness components.

A Global Framework

WHO’s Pandemic Influenza Preparedness (PIP) Framework aims to implement a global approach to pandemic influenza preparedness and response. Its stated scope makes preparedness a matter of international coordination, not only domestic planning. The source description does not specify particular measures or assess how well the framework has been implemented.

Preparedness Across Communities

WHO’s Unity Studies initiative provides standardized protocols intended to support respiratory pathogen pandemic preparedness through health systems during the interpandemic period. OpenLearn’s influenza case study describes the 2009 swine flu pandemic as causing widespread panic in parts of the world, although it resulted in relatively few fatalities. Imperial College London describes more than 120 multidisciplinary research groups working in pandemic preparedness, alongside participation in global collaborative trials, networks, and advisory groups. The CDC Museum notes that preparedness has advanced since 1918 but remains shaped by political, social, and cultural context, with room for improvement.

What the 2015 assessment can tell us

The reported capabilities cover pieces of a response chain: recognizing a novel virus and moving laboratory and epidemiology data. The assessment’s focus on these modules does not by itself establish how well multiple capabilities or agencies would coordinate in a pandemic.[1] [2]

Where the capacity findings are weakest

  • The report says additional planning and technical assistance are needed to help jurisdictions maintain critical capacities over time.[1]

How public health jurisdictions reported their readiness

PopulationRepresentatives from 62 PHEP awardee jurisdictions[1]
Sample size62 jurisdictions[1]
SettingUnited States and territories[1]
Times cited3[1]

How later work relates to readiness measurement

A later school-based study described daily tracking of influenza-like-illness absences as an approach being assessed for early detection in schools and nearby communities. That is a different kind of monitoring from the jurisdiction-level capacity inventory summarized in the PIRA report.[1] [3]

Subsequent pandemic planning material describes specimen-submission calculators used to help determine which influenza-positive samples public health laboratories send to reference centers. This illustrates an operational surveillance process, not a reported evaluation of PIRA’s results.[1] [4]

What a follow-up assessment would need to establish

  • Did the training and outreach informed by the assessment help jurisdictions maintain critical capabilities over time?[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1089/hs.2018.0021, Alternate LINK

Title: Pandemic Influenza Readiness Report On Laboratory And Epidemiology Capacity—United States And Territories, 2015

Subject: Health, Toxicology and Mutagenesis

Journal: Health Security

Publisher: Mary Ann Liebert Inc

Authors: Luis Lowe, Stephanie A. Dopson, Alicia P. Budd

Published: 2018-08-01

Everything You Need To Know

1

What is the Pandemic Influenza Readiness Assessment (PIRA)?

The Pandemic Influenza Readiness Assessment (PIRA) is a comprehensive evaluation conducted by the Centers for Disease Control and Prevention (CDC) in 2015. It was designed to gauge the United States' preparedness for an influenza pandemic, focusing specifically on the laboratory and epidemiology capacities of public health jurisdictions across the country. Its goal was to identify strengths and weaknesses in the public health system's ability to detect, respond to, and manage a potential influenza pandemic.

2

Why is it so important to be able to tell the difference between novel influenza A viruses and the regular seasonal flu?

The ability to differentiate novel influenza A viruses from seasonal influenza viruses is crucial because it allows for the early detection and characterization of new, potentially pandemic influenza strains. This differentiation is essential for implementing timely and appropriate public health interventions, such as developing targeted vaccines and antiviral treatments, and enacting effective control measures to prevent widespread transmission. Without this capability, it would be difficult to distinguish between a regular seasonal flu and a potentially deadly pandemic strain, leading to delays in response and potentially more severe outcomes.

3

Why is electronically transferring data so important during a potential outbreak?

The electronic transfer of laboratory, surveillance, and case investigation data is vital for ensuring rapid communication and coordination among public health agencies during a pandemic. This capability enables real-time tracking of the spread of the virus, identification of high-risk populations, and monitoring of the effectiveness of interventions. The rapid exchange of information helps in making informed decisions and allocating resources efficiently. The transfer of electronic death records is another important aspect as it aids in monitoring the mortality rate associated with the pandemic and understanding its impact on the population.

4

What was a key weakness found in the Pandemic Influenza Readiness Assessment (PIRA)?

A key weakness identified in the Pandemic Influenza Readiness Assessment (PIRA) was the variable ability among jurisdictions to rapidly identify and characterize novel influenza strains. This means that not all states and territories had the necessary resources, training, or infrastructure to quickly detect and analyze new influenza viruses that could potentially cause a pandemic. Addressing this gap is crucial because the faster a novel strain is identified and characterized, the faster public health officials can develop and implement effective countermeasures, such as vaccines and antiviral drugs.

5

How does the Pandemic Influenza Readiness Assessment (PIRA) help with future pandemic planning?

The Pandemic Influenza Readiness Assessment (PIRA) report guides future efforts to enhance pandemic preparedness by pinpointing specific areas where improvements are needed. By understanding the strengths and weaknesses of the public health system, resources can be directed more effectively to address gaps in capabilities. This includes investing in public health infrastructure, providing training to healthcare professionals, and supporting research to develop new diagnostic tools and treatments. Continuous investment is essential to protect the health and well-being of communities and to prepare for future threats.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.